Principal cancers among women: Breast, lung and colorectal

International Journal of Fertility and Menopausal Studies

Volumn 41, Issue 2, 1996, Pages 166-171

  Rozenberg, S ^a   Liebens, F ^a   Kroll, M ^a   Vandromme, J ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

breast cancer; colorectal cancer; estrogen replacement therapy; lung cancer; menopause; smoking; women's health

Indexed keywords

ESTROGEN;

BREAST CANCER; COLORECTAL CANCER; CONFERENCE PAPER; FEMALE; HORMONE SUBSTITUTION; HUMAN; LUNG CANCER; MENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; PROGNOSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; WOMEN'S HEALTH;

EID: 0030004604     PISSN: 10693130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Sarna L: Lung cancer: the overlooked women's health priority. Cancer Practice 3:13-18, 1995.
2. Harris JR, Lippman ME, Veronesi U, et al: Breast cancer. N EnglJMed 332(19): 1245-1250, 1992.
3. Thirlaway K, Fallowfield L: The psychological consequences of being at risk of developing breast cancer. EUT J Cancer Pievent 2: 467-471, 1993.
4. Liebens F, Aimont M, Plas C, et al: Psychological support program in breast cancer surgery: a necessity. 7th International Congress on Senology 3-7 May 1992, Rhodes, Greece.
5. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 273(7): 577-585, 1995.
6. Claus ER, Risch NJ, Thompson WD: Age at diagnosis as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961-972, 1990.
7. Peeters Ph, Verbeek A, Krol A, et al: Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res Treat 33(1): 55-61, 1995.
8. Steinberg KK, Smith SJ, Thacker SB, et al: Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 5(4): 415-21, 1994.
9. Colditz GA, Hankinson SE, Hunter DJ, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N EnglJMed 332:1589-1593, 1995.
10. Stanford JL, Weiss NS, Voigt LF, et al: Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J Am Med Assoc 274:137-142, 1995.
11. Cobleigh MA, Berris RF, Bush T, et al: The Breast Cancer Committees of the Eastern Cooperative Oncology Group. Estrogen replacement therapy in breast cancer survivors. A time for change. J Am Med Assoc 272:540-545, 1994.
12. Theriault RL, Sellin RV: Estrogen replacement therapy in younger women with breast cancer. Monogr Natl Cancer Inst 16:149-152, 1994.
13. Katsouyanni K, Trichopoulou A, Stuver S, et al: Ethanol and breast cancer: an association that may be both confounded and causal. Int J Cancer 58(3): 356-361, 1994.
14. Fuchs CS, Stampfer MJ, Colditz GA, et al: Alcohol consumption and mortality among women. N Engl J Med 332(19):1245-1250, 1995.
15. van den Brandt PA, Goldbohm RA, van't Veer P: Alcohol and breast cancer: results from The Netherlands Cohort Study. Am J Epidemiol 141(10): 907-915, 1995.
16. Wald NJ, Chamberlain J, Hackshaw A: European Society of Mastology. Consensus Conference on Breast Cancer Screening Paris, 4-5 February 1993. Report of the Evaluation Committee. Bull Cancer 81:825-834, 1994.
17. Alexander FE, Anderson TJ, Brown HK, et al: The Edinburgh randomized trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 70(3): 542-548, 1994.
18. Kerlikowske K, Grady D, Rubin SM, et al: Efficacy of screening mammography. A meta-analysis. JAMA 273(2):149-154, 1995.
19. Feig SA: Mammographie screening of women aged 40 to 49 years. Is it justified? Obstet Gynecol Clin North Am 21(4): 587-606, 1994.
20. Peer PG, Werre JM, Mravunac M, et al: Effect on breast cancer mortality of biennial mammographie screening of women under age 50. Int J Cancer 60(6): 808-811, 1995.
21. Tabar L, Fagerberg G, Chen HH, et al: Efficacy of breast cancer screening by age. New results from the Swedish TwoCounty Trial. Cancer 75(10): 2507-2517, 1995.
22. Samet JM: The epidemiology of lung cancer. Chest 103:20s-29s, 1993.
23. Ernster VI: The epidemiology of lung cancer in women. Ann Epidemiol 4:102-110, 1994.
24. Muscat JE, Wynder EL: Lung cancer pathology in smokers, ex-smokers and never smokers. Cancer Lett 88:1-5, 1995.
25. Wu AH, Fontman ETH, Reynolds P, et al: Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141:1023-1032, 1995.
26. Soda H, Tomita H, Kohno S, et al: Limitation of annual screening chest radiography for the diagnosis of lung cancer. Cancer 72(8):2341-2346, 1993.
27. Smart CR: Annual screening using chest X-ray examination for the diagnosis of lung cancer (Editorial). Cancer 72(8):2295-2298, 1993.
28. Cooper GS, Yuan Z, Landefeld S, et al: A national population-based study of incidence of colorectal cancer and âge. Cancer 75:775-781, 1995.
29. Fuchs CS, Giovannucci EL, Colditz GA, et al: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331(25):1669-1674, 1995.
30. Giovannucci E, Colditz GA, Stampfer MJ, et al: A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. J Natl Cancer Inst 86:192-199, 1994.
31. Giovannucci E, Stampfer MJ, Colditz, et al: Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85(11):875-884, 1993.
32. Calle EE, Miracle-McMahill HL, et al: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87:517-523, 1995.
33. Eisen GM, Sandler RS: Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol 19(1): 57-63, 1994.